4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-21-023880
Director sold 10,000 shares at an average $126.61 ($1,266,118)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2021-06-11 | Sale | −5,427 | $125.62 | $681,753 | 24,948 | D: show line 1 in the form |
| Bolzon Bradley J PhD Director | 2021-06-11 | Sale | −1,918 | $126.59 | $242,808 | 23,030 | D: show line 2 in the form |
| Bolzon Bradley J PhD Director | 2021-06-11 | Sale | −800 | $127.88 | $102,307 | 22,230 | D: show line 3 in the form |
| Bolzon Bradley J PhD Director | 2021-06-11 | Sale | −1,100 | $128.65 | $141,517 | 21,130 | D: show line 4 in the form |
| Bolzon Bradley J PhD Director | 2021-06-11 | Sale | −755 | $129.45 | $97,733 | 20,375 | D: show line 5 in the form |
| Open-market sales · 10,000 sh · avg $126.61 · $1,266,118 | |||||||
Loading xslF345X03/doc4.xml…